These results indicated that TNBC cell lines MDA-MB-231, MDA-MB-468, and HCC-1937, as well as HER2 positive cell line SK-BR-3, are sensitive to the cytotoxic effect of lapatinib. This evidence concerns the gene ERBB2 and hepatocellular carcinoma.